Skip to main content
SpringerLink
Log in
Book cover

Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases pp 353–363Cite as

Disorders of Copper, Zinc, and Iron Metabolism

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bale PM, Kan AE, Dorney SF (1994) Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol 14:479–489

    CAS  PubMed  Google Scholar 

  2. Brewer GJ, Hedera P, Kluin KJ, et al. (2003) Treatment ofWilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60:379–385

    Article  PubMed  Google Scholar 

  3. Camaschella C, Roetto A, DeGobbi M (2002) Juvenile hemochromatosis. Semin Hematol 39:242–248

    Article  PubMed  Google Scholar 

  4. Christodoulou J, Danks DM, Sarkar B, et al. (1998) Early treatment of Menkes disease with parenteral copper-histidine: long-termfollow-up of four treated patients. Am J Med Genet 76:154–164

    Article  CAS  PubMed  Google Scholar 

  5. Dufner-Beattie J, Wang F, Kuo YM, Gitschier J, Eide D, Andrews GK (2003) The acrodermatitis enteropathica gene ZIP4 encodes a tissue-specific, zinc-regulated zinc transporter in mice. J Biol Chem 278:33474–33481

    CAS  PubMed  Google Scholar 

  6. Feder JN, Gnirke A, Thomas W, et al. (1996) A novel MHC class I-like gene ismutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408

    Article  CAS  PubMed  Google Scholar 

  7. Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO (1998) Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 351:490–493

    Article  CAS  PubMed  Google Scholar 

  8. Goldfischer S, Grotsky HW, Chang CH, et al. (1981) Idiopathic neonatal iron storage involving the liver, pancreas, heart, and endocrine and exocrine glands. Hepatology 1:58–64

    CAS  PubMed  Google Scholar 

  9. Kelly AL, Lunt PW, Rodrigues F, et al. (2001) Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 38:599–610

    Article  CAS  PubMed  Google Scholar 

  10. Knisely AS, Mieli-Vergani G, Whitington PF (2003) Neonatal hemochromatosis. Gastroenterol Clin North Am 32:877–889

    Article  CAS  PubMed  Google Scholar 

  11. Lee JY, Chang SE, Suh CW, et al. (2002) A case of acrodermatitis enteropathica-like dermatosis caused by ornithine transcarbamylase deficiency. J Am Acad Dermatol 46:965–967

    PubMed  Google Scholar 

  12. Miyajima H, Takahashi Y, Kono S (2003) Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 16:205–213

    Article  CAS  PubMed  Google Scholar 

  13. Montosi G, Donovan A, Totaro A, et al. (2001) Autosomal-dominant hemochromatosis is associated with amutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623

    Article  CAS  PubMed  Google Scholar 

  14. Njajou OT, Vaessen N, Joosse M, et al. (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213–214

    Article  CAS  PubMed  Google Scholar 

  15. Papanikolaou G, Samuels ME, Ludwig EH, et al. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82

    Article  CAS  PubMed  Google Scholar 

  16. Phillips MJ, Ackerley CA, Superina RA, Roberts EA, Filler RM, Levy GA (1996) Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children. Lancet 347:866–868

    Article  CAS  PubMed  Google Scholar 

  17. Roetto A, Daraio F, Alberti F, et al. (2002) Hemochromatosis due to mutations in transferrin receptor 2. Blood Cells Mol Dis 29:465–470

    CAS  PubMed  Google Scholar 

  18. Roetto A, Papanikolaou G, Politou M, et al. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22

    Article  CAS  PubMed  Google Scholar 

  19. Roberts EA, Schilsky ML (2003) A practice guideline on Wilson disease. Hepatology 37:1475–1492

    Article  PubMed  Google Scholar 

  20. Sarkar B, Lingertat-Walsh K, Clarke JT (1993) Copper-histidine therapy for Menkes disease. J Pediatr 123:828–830

    CAS  PubMed  Google Scholar 

  21. Shamieh I, Kibort PK, Suchy FJ, Freese DK (1993) Antioxidant therapy for neonatal iron storage disease (NISD) (abstract). Pediatr Res 33:109 A

    Google Scholar 

  22. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS (1998) Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 26:85–89

    Article  CAS  PubMed  Google Scholar 

  23. Tavill AS (2001) Diagnosis and management of hemochromatosis. Hepatology 33:1321–1328

    Article  CAS  PubMed  Google Scholar 

  24. Verloes A, Lombet J, Lambert Y, et al. (1997) Tricho-hepato-enteric syndrome: further delineation of a distinct syndromewith neonatal hemochromatosis phenotype, intractable diarrhea, and hair anomalies. Am J Med Genet 68:391–395

    CAS  PubMed  Google Scholar 

  25. Visapaa I, Fellman V, Vesa J, et al. (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a pointmutation in BCS1L. Am J Hum Genet 71:863–876

    PubMed  Google Scholar 

Download references

Authors
  1. Eve A. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Clinical Chemistry and Biochemistry, University Children’s Hospital, Steinwiesstrasse 75, 8032, Zurich, Switzerland

    Nenad Blau

  2. Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, 30, Guilford Street, London, WC1N 1EH, UK

    James Leonard

  3. Universitätsklinik für Kinder- und Jugendmedizin, Im Neuenheimer Feld 150, D-69120, Heidelberg, Germany

    Georg F. Hoffmann

  4. Division of Clinical & Metabolic Genetics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada

    Joe T. R. Clarke

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Roberts, E.A. (2006). Disorders of Copper, Zinc, and Iron Metabolism. In: Blau, N., Leonard, J., Hoffmann, G.F., Clarke, J.T.R. (eds) Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28962-3_35

Download citation

  • DOI: https://doi.org/10.1007/3-540-28962-3_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22954-4

  • Online ISBN: 978-3-540-28962-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation